KR100893912B1 - Anti-wrinkle Cosmetics comprising Paeonia lactiflora and Gastrodia elata extracts as an effective component - Google Patents
Anti-wrinkle Cosmetics comprising Paeonia lactiflora and Gastrodia elata extracts as an effective component Download PDFInfo
- Publication number
- KR100893912B1 KR100893912B1 KR1020070100456A KR20070100456A KR100893912B1 KR 100893912 B1 KR100893912 B1 KR 100893912B1 KR 1020070100456 A KR1020070100456 A KR 1020070100456A KR 20070100456 A KR20070100456 A KR 20070100456A KR 100893912 B1 KR100893912 B1 KR 100893912B1
- Authority
- KR
- South Korea
- Prior art keywords
- peony
- extract
- filtrate
- cheonma
- minutes
- Prior art date
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8988—Gastrodia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
본 발명은 작약 및 천마추출물을 유효 성분으로 포함하는 주름개선용 기능성 화장품에 관한 것으로, The present invention relates to a functional cosmetic for wrinkle improvement comprising peony and cheonma extract as an active ingredient,
작약 추출물 및 천마추출물은 각각 (a)0.5~1.0cm 크기로 절단된 작약근 및 천마건조분말을 준비하는 단계; (b)상기 작약근 및 천마건조분말에 8~12배의 증류수를 가하고, 이를 90~97℃의 온도에서 210~270분 및 450~510분 동안 열수 추출한 다음 여과액으로 여과시키는 단계; (c)상기 여과액을 50~55℃의 온도에서 감압 농축한 다음, 실온까지 냉각하는 단계; (d)상기 (c)단계에서 생성된 물질이 70~80% 범위의 에탄올 용액이 되도록 에탄올을 가하는 단계; (e)상기 (d)단계에서 생성된 물질을 3~7℃ 범위에서 210~270분 동안 방치한 다음, 여과액을 동결건조하는 단계; 를 통하여 제조되는 것을 특징으로 한다. Peony extract and cheonma extract is (a) preparing peony root and cheonma dry powder cut into sizes of 0.5 ~ 1.0cm, respectively; (b) adding 8-12 times distilled water to the peony root and cheonma dry powder, extracting the hydrothermal extract for 210 to 270 minutes and 450 to 510 minutes at a temperature of 90 to 97 ° C., and then filtering the filtrate with filtrate; (c) concentrating the filtrate under reduced pressure at a temperature of 50-55 ° C. and then cooling to room temperature; (d) adding ethanol such that the material produced in step (c) becomes an ethanol solution in a range of 70 to 80%; (e) leaving the material produced in step (d) in a range of 3 to 7 ° C. for 210 to 270 minutes, and then lyophilizing the filtrate; It is characterized in that it is manufactured through.
작약, 천마, 주름, 화장품Peony, celestial horse, wrinkle, cosmetic
Description
본 발명은 작약 및 천마추출물을 유효 성분으로 포함하는 주름개선용 기능성 화장품에 관한 것이다.The present invention relates to a functional cosmetic for wrinkle improvement comprising peony and cheonma extract as an active ingredient.
피부 노화는 크게 내인성 노화와 광노화(photoaging)로 나눌 수 있는데, 이중 광노화 현상은 자외선의 노출을 피하면 예방할 수 있는 피부 노화 현상이다. 그러나 현재 자외선을 차단하여 피부노화를 억제하는 기능성 화장품을 비롯하여 주름 개선용 기능성 화장품의 대부분은 그 원료를 수입에 의존하고 있어, 이로 인한 비용 지출이 큰 부분을 차지하고 있다.Skin aging can be largely divided into endogenous aging and photoaging, which is a skin aging phenomenon that can be prevented by avoiding exposure to ultraviolet rays. However, most of the functional cosmetics for improving wrinkles, including functional cosmetics that block skin aging by blocking ultraviolet rays, rely on imports of the raw materials, and thus, a large portion of the expenses are accounted for.
삭제delete
그러나 천연한방 식물인 작약은 고부가가치의 약용식물로써, 그 주성분인 페오니플로린(paeoniflorin)은 중추억제 작용, 혈관확장 작용, 항산화 작용 등의 효능이 있는 것으로 알려져 있다. 아울러 천마의 경우 풍증의 치료 또는 어혈 증상의 개선을 목적으로 널리 사용되어 온 생약재로서, 근래에 재배방법이 개발되어 대량으로 생산할 수 있는 기반이 마련되어 있는 실정이다.However, peony, a natural herbaceous plant, is a high-value medicinal plant, and its main ingredient, peoniflorin, is known to have a central inhibitory effect, vasodilation, and antioxidant activity. In addition, in the case of cheonma as a herbal medicine that has been widely used for the treatment of bouts of affairs or to improve the blood symptoms, the cultivation method has been developed in recent years has a foundation that can be produced in large quantities.
상기와 같은 문제점을 해결하기 위하여 창작된 본 발명의 목적은 다음과 같다.An object of the present invention created to solve the above problems is as follows.
첫째, 작약 및 천마추출물을 유효 성분으로 하여 주름 개선의 기능성이 부여된 주름개선용 기능성 화장품을 제공하고자 한다. First, to provide a functional cosmetics for wrinkle improvement with the functionality of wrinkle improvement using peony and cheonma extract as an active ingredient.
삭제delete
둘째, 국내 천연소재를 이용한 생리활성 신소재의 연구를 통하여 천연자원에 대한 경제적 효용가치 증가시키고, 이들 자원의 고부가가치화를 실현하고자 한다.Second, through the study of bioactive new materials using natural materials in Korea, we will increase the economic utility value of natural resources and realize high added value of these resources.
상기와 같은 과제를 해결하기 위하여 본 발명은 작약 및 천마추출물을 유효 성분으로 포함하는 주름개선용 기능성 화장품을 제공한다.In order to solve the above problems, the present invention provides a functional cosmetic for wrinkle improvement comprising peony and cheonma extract as an active ingredient.
여기에서 본 발명의 작약 추출물 및 천마추출물은 각각 (a)0.5~1.0cm 크기로 절단된 작약근 및 천마건조분말을 준비하는 단계; (b)상기 작약근 및 천마건조분말에 8~12배의 증류수를 가하고, 이를 90~97℃의 온도에서 210~270분 및 450~510분 동안 열수 추출한 다음 여과액으로 여과시키는 단계; (c)상기 여과액을 50~55℃의 온도에서 감압 농축한 다음, 실온까지 냉각하는 단계; (d)상기 (c)단계에서 생성된 물질이 70~80% 범위의 에탄올 용액이 되도록 에탄올을 가하는 단계; (e)상기 (d)단계에서 생성된 물질을 3~7℃ 범위에서 210~270분 동안 방치한 다음, 여과액을 동결건조하는 단계; 를 통하여 제조된다. Here, the peony extract and cheonma extract of the present invention comprises the steps of (a) preparing peony root and cheonma dry powder cut into 0.5 ~ 1.0cm size; (b) adding 8-12 times distilled water to the peony root and cheonma dry powder, extracting the hydrothermal extract for 210 to 270 minutes and 450 to 510 minutes at a temperature of 90 to 97 ° C., and then filtering the filtrate with filtrate; (c) concentrating the filtrate under reduced pressure at a temperature of 50-55 ° C. and then cooling to room temperature; (d) adding ethanol such that the material produced in step (c) becomes an ethanol solution in a range of 70 to 80%; (e) leaving the material produced in step (d) in a range of 3 to 7 ° C. for 210 to 270 minutes, and then lyophilizing the filtrate; It is manufactured through.
삭제delete
이상과 같은 본 발명에 따르면 천연 성분인 작약 및 천마추출물을 유효 성분으로 포함하는 주름개선용 기능성 화장품을 통하여, 국내 천연자원에 대한 경제적 효용가치 증가와 함께 이들 자원의 고부가가치화를 실현할 수 있다.According to the present invention as described above through the functional cosmetics for improving wrinkles, including peony and cheonma extract as a natural ingredient as an active ingredient, it is possible to realize a high value-added of these resources with an increase in economic utility value for domestic natural resources.
삭제delete
삭제delete
삭제delete
본 발명은 작약추출물 및 천마추출물을 유효성분으로 포함하는 주름개선용 기능성 화장품인바, 작약 및 천마추출물의 추출 방법 및 실시예에 대하여 살펴보고, 이를 포함하여 구성되는 주름개선용 기능성 화장품의 효능에 대하여 실험예를 통하여 검증하고자 한다.The present invention is an anti-wrinkle functional cosmetics containing peony extract and cheonma extract as an active ingredient, look at the extraction method and embodiment of the peony and cheonma extract, with respect to the efficacy of the functional cosmetic for wrinkle improvement comprising the same This will be verified through an experimental example.
■ 작약 및 천마추출물의 제조 ■ Manufacture of Peony and Cinnamon Extract
작약은 천궁, 당귀, 지황, 황기와 함께 국내 5대 기본 생약재 중의 하나로서, 작약의 품질을 평가하는 지표물질로는 작약근의 주요 생리활성물질인 페오니플로린(paeoniflorin)이 사용된다. 작약을 식품이나 화장품의 소재로 사용할 경우, 안전성과 추출설비 및 제조 단가 등에 장점이 많은 열수 추출을 이용하도록 한다. Peony is one of the five basic herbal medicines in Korea, along with Cheongung, Angelica, Chihwang, and Astragalus. Peonyniflorin, the main bioactive substance of peony root, is used as an indicator for evaluating the quality of peony. If peony is used as a material for food or cosmetics, hot water extraction should be used, which has many advantages in safety, extraction equipment, and manufacturing cost.
천마의 경우 주요생리활성물질인 게스트로딘(gastrodin), 베닐릴알콜(benzyl alcohol), 바닐린(vanillin) 등은 물에서 추출이 용이하므로, 이러한 특성을 이용하여 열수 추출하였다.In the case of Chunma, gastrodin, benzyl alcohol, vanillin, etc., which are the main bioactive substances, are easily extracted from water, and thus hot water was extracted using these properties.
여기에서 작약 추출물 및 천마추출물은 각각 (a)0.5~1.0cm 크기로 절단된 작약근 및 천마건조분말을 준비하는 단계; (b)상기 작약근 및 천마건조분말에 8~12배 의 증류수를 가하고, 이를 90~97℃의 온도에서 210~270분 및 450~510분 동안 열수 추출한 다음 여과액으로 여과시키는 단계; (c)상기 여과액을 50~55℃의 온도에서 감압 농축한 다음, 실온까지 냉각하는 단계; (d)상기 (c)단계에서 생성된 물질이 70~80% 범위의 에탄올 용액이 되도록 에탄올을 가하는 단계; (e)상기 (d)단계에서 생성된 물질을 3~7℃ 범위에서 210~270분 동안 방치한 다음, 여과액을 동결건조하는 단계; 를 통하여 제조되는 것을 특징으로 한다. Here, peony extract and cheonma extract are prepared by (a) preparing peony root and cheonma dry powder cut into 0.5 ~ 1.0cm size; (b) adding 8-12 times distilled water to the peony root and cheonma dry powder, extracting the hydrothermal extract for 210-270 minutes and 450-510 minutes at a temperature of 90-97 ° C., and then filtering the filtrate with filtrate; (c) concentrating the filtrate under reduced pressure at a temperature of 50-55 ° C. and then cooling to room temperature; (d) adding ethanol such that the material produced in step (c) becomes an ethanol solution in a range of 70 to 80%; (e) leaving the material produced in step (d) in a range of 3 to 7 ° C. for 210 to 270 minutes, and then lyophilizing the filtrate; It is characterized in that it is manufactured through.
[[ 실시예Example ]]
1. 작약추출물의 제조1. Preparation of Peony Extract
작약추출물을 생산하기 위하여, 본 발명의 실시예로 작약근 300g을 0.5㎝~1㎝ 크기로 절단한 시료에 증류수 3000㎖을 가한 다음, 환류냉각기를 부착하여 95℃에서 4시간 열수추출하고 이를 여과한다. 그리고 이 여과액을 50~55℃에서 전량이 200㎖될 때까지 감압농축기로 농축하여 실온까지 냉각한 다음, 에탄올을 가하여 75%에탄올 용액이 되게 한다. 다음으로 이를 교반하여 5℃에서 24시간 방치하고 생성되는 침전물을 제거한다. 이렇게 획득된 여과액을 동결건조함으로써 작약의 유용물질이 함유된 작약추출물을 생산한다. (도1).In order to produce a peony extract, 3000 ml of distilled water was added to a sample cut into 300 g of peony root in a size of 0.5 cm to 1 cm according to an embodiment of the present invention, followed by attaching a reflux condenser and extracting hot water at 95 ° C. for 4 hours and filtering it. do. The filtrate is concentrated in a vacuum condenser until the total amount is 200ml at 50 ~ 55 ° C, cooled to room temperature, and ethanol is added to make 75% ethanol solution. Next, it is stirred and left for 24 hours at 5 ° C. to remove the resulting precipitate. By freeze-drying the filtrate thus obtained to produce a peony extract containing the useful material of the peony. (Figure 1).
2. 천마추출물의 제조2. Preparation of Cheonma Extract
천마추출물은 작약추출물과 마찬가지로 도1과 같은 순서를 따라 생산하였다. 여기에서는 천마건조분말을 사용하였으며, 천마가 작약에 비하여 열에 안정적인 특 성을 이용하여 8시간 동안 열수 추출하였다.Chunma extract was produced in the same order as in Fig. 1 as peony extract. Here, cheonma dry powder was used, and hot water was extracted for 8 hours using heat-stable properties compared to peony.
3. 작약 및 천마추출물의 추출 수율3. Extraction yield of peony and cheonma extract
상기 실시예를 통하여 획득된 작약 및 천마추출물의 추출 수율은 표1과 같다. 이때 작약 및 천마추출물의 최종 수득률은 각각 26.5% 및 52.5%이다.Extraction yield of peony and cheonma extract obtained through the above embodiment is shown in Table 1. The final yield of peony and cheonma extract is 26.5% and 52.5%, respectively.
[표1]Table 1
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
삭제delete
■ 주름개선용 기능성 화장품의 피부노화 억제 효능 ■ Anti-aging effect of wrinkles functional cosmetics
피부노화는 엠엠피(matrix metalloproteinase;MMP)의 일종인 콜라게나아제를 활성화시켜 콜라겐(교원질) 또는 기질단백질(extracellula matrix;ECM)의 파괴를 통하여 세포벽을 파괴시킴으로써 유발된다. 특히 자외선은 콜라겐의 양을 감소시킴과 동시에 MMP-1의 양을 증가시켜 피부 주름을 형성한다(도2). 따라서 본 발명에서는 인체 상피세포(CCD986SK) 및 각질세포(HaCaT)를 이용하여 ECM의 가장 중요한 성분인 콜라겐의 합성 정도 등과 MMP-1(collagenase-1) 또는 MMP-13(collagenase-3)의 합성 정도 등을 조사하였으며, 아울러 UVA(장파장 자외선)를 조사 후 작약 및 천마추출물의 MMPs 활성 정도 등을 측정하였다.Skin aging is caused by activating collagenase, a type of matrix metalloproteinase (MMP), which destroys cell walls through the destruction of collagen (collagen) or extracellula matrix (ECM). In particular, ultraviolet rays reduce the amount of collagen and at the same time increase the amount of MMP-1 to form skin wrinkles (Fig. 2). Therefore, in the present invention, the degree of synthesis of collagen, which is the most important component of ECM, and the degree of synthesis of MMP-1 (collagenase-1) or MMP-13 (collagenase-3) using human epithelial cells (CCD986SK) and keratinocytes (HaCaT). In addition, after irradiation of UVA (long wavelength UV), the degree of MMPs activity of peony and cheonma extract were measured.
실험의 진행이전에 인체 상피세포인 CCD986SK와 각질세포인 HaCaT를 일정 조건하에서 배양하였다. Before the experiment, human epithelial cells, CCD986SK and keratinocytes, HaCaT, were cultured under certain conditions.
[실험예1] 작약 및 천마추출물의 콜라겐 합성 촉진 효능Experimental Example 1 Collagen Synthesis Promoting Effect of Peony and Chunma Extract
1. 실험방법1. Experimental method
ECM의 가장 중요한 성분인 콜라겐의 합성 촉진효과를 조사하기 위하여 CCD986SK 세포 및 HaCaT 세포를 배양 후 작약 및 천마추출물을 처리하고 24시간 후에 상층액을 회수하여 그 중 200㎕를 Sircol red 용액 1㎖와 혼합하였다. 그리고 이를 상온에서 30분간 반응시키면서 5분마다 한 번씩 섞은 다음 10,000 rpm에서 10분간 원심분리 하였다. 이 상층액을 버리고 침전물을 0.4N NaOH 1㎖에 녹여서 흡광도 550nm에서 측정하였다.In order to investigate the synergistic effect of collagen, the most important component of ECM, after treatment with CCD986SK cells and HaCaT cells, the peony and cheonma extract were treated, and after 24 hours, the supernatant was recovered and 200 μl was mixed with 1 ml of Sircol red solution. It was. The mixture was mixed once every 5 minutes while reacting at room temperature for 30 minutes and then centrifuged at 10,000 rpm for 10 minutes. This supernatant was discarded and the precipitate was dissolved in 1 ml of 0.4N NaOH and measured at an absorbance of 550 nm.
2. 실험결과2. Experimental Results
도3 및 도4에서 볼 수 있는 바와 같이, 작약 및 천마추출물을 처리했을 때 콜라겐의 합성이 촉진되는 것을 확인할 수 있다.As can be seen in Figures 3 and 4, it can be seen that the synthesis of collagen is accelerated when the peony and cheonma extract are treated.
[실험예2] ELISA를 이용한 콜라겐 합성 촉진 효능Experimental Example 2 Collagen Synthesis Promoting Effect Using ELISA
1. 실험방법1. Experimental method
병소감염진단테스트(enzyme-linked immunosorbent assay;ELISA)를 통하여 콜라겐의 합성 촉진 효능을 측정하였다. 즉 CCD986SK 세포를 48 well plate에 계대 배양 후 작약 및 천마추출물을 처리하고 24시간 후에 상층액을 회수한 다음, 이를 96 well plate에 100㎕씩 분주하여 24시간 동안 항원을 부착시킨 후 세척하였다. 그리고 I형 콜라겐의 합성 지표로 사용되는 1차 항체(procollagen type I N-terminal propeptide;PICP)를 각 well당 100㎕ 넣어 상온에서 2시간 반응시키고 세척하였다. 그리고 2차 항체(anti-mouse)를 희석하고, 각 well당 이를 100㎕씩 넣어 실온에서 2시간 반응시킨 다음, 다시 이를 세척하여 티엠이(3,3',5,5'-Tetramethyl-benzidine;TMB)를 100㎕씩 각 well에 분주하였다. 그리고 이의 발색 반응 후 2N H2SO4 50㎕씩을 넣고 기질 반응을 정지시켰다. 흡광도는 ELISA 리더로 450nm에서 측정하였다. Enzyme-linked immunosorbent assay (ELISA) was used to measure the effect of promoting collagen synthesis. That is, the CCD986SK cells were passaged in 48 well plates, treated with peony and cheonma extract, and after 24 hours, the supernatant was collected, and then, 100 µl was dispensed into 96 well plates, and the antigens were attached and washed for 24 hours. In addition, 100 μl of a primary antibody (procollagen type I N-terminal propeptide; PICP), which is used as an index of synthesis of type I collagen, was added to each well for 2 hours at room temperature and washed. After diluting the secondary antibody (anti-mouse), 100 μl of each well was reacted at room temperature for 2 hours, and then washed again to make TEM (3,3 ', 5,5'-Tetramethyl-benzidine; TMB) was aliquoted into each well. After the color reaction, 50N of 2N H 2 SO 4 was added thereto to stop the substrate reaction. Absorbance was measured at 450 nm with ELISA reader.
2. 실험결과2. Experimental Results
CCD986SK 세포에 작약 및 천마추출물을 처리하고 PICP 항체를 이용하여 콜라겐의 합성 촉진 효과를 ELISA로 수행한 결과, 작약 및 천마추출물에서 콜라겐의 합성이 촉진되는 것을 확인할 수 있다(도5).Treatment of peony and cheonma extracts on CCD986SK cells and the effect of promoting collagen synthesis by ELISA using PICP antibody were confirmed that the synthesis of collagen is promoted in peony and cheonma extract (FIG. 5).
[실험예3] 형질전환Experimental Example 3 Transformation
1. 실험방법1. Experimental method
작약 및 천마추출물의 교원질 촉진자 유전자(collagen alpha2(I) gene;COL1A2) 전사 활성도에 대한 효과를 측정하기 위하여 COL1A2의 프로모터(promoter)를 루시페라아제 (luciferase)를 포함하는 벡터 업스트림(vector(pGL3-promoter) upstream)에 삽입시켜 재조합 플라스미드를 만들고, COL1A2 전사촉진제의 활성도에 의존적으로 루시페라아제가 발현되도록 하였다. 그리고 CCD986SK 세포에 Lipofectamine를 이용하여 pGL3-COL1A2를 형질전환시킨 후, CCD986SK 세포를 48 well plate에 계대 배양하고, 여기에 작약 및 천마추출물을 처리하여 24 시간 동안 배양하였다. 다음으로 이의 융해물을 만들어 상층액만 취하여 리포터 유전자 에세이(reporter gene assay)를 수행하여 루시페라아제의 활성도를 측정하였다.In order to measure the effect of collagen alpha2 (I) gene (COL1A2) transcriptional activity of peony and spermatozoa extracts, the promoter of COL1A2 was vectored upstream (luciferase) vector (pGL3-promoter) containing luciferase. upstream) to generate recombinant plasmids and allow luciferase to be expressed depending on the activity of the COL1A2 promoter. After transforming pGL3-COL1A2 using Lipofectamine to CCD986SK cells, the CCD986SK cells were passaged in 48 well plates, and then treated with peony and cheonma extract, and incubated for 24 hours. Next, the lysate was made, and only the supernatant was taken to carry out a reporter gene assay to measure the activity of luciferase.
2. 실험결과2. Experimental Results
천마추출물과 작약 추출물 모두에서 COL1A2 promoter의 전사 활성도가 증가된 것을 확인할 수 있다.(도6). It can be seen that the transcriptional activity of the COL1A2 promoter was increased in both the extract and the peony extract (FIG. 6).
[실험예4] 작약 및 천마추출물의 콜라게나아제 활성 저해 효능Experimental Example 4 Inhibitory Effect of Peony and Chunma Extract on Collagenase Activity
1. 실험방법1. Experimental method
ECM의 가장 중요한 성분인 콜라게나아제 활성 중 MMP-1 및 MMP-13의 활성 억제 효과를 조사하기 위하여 CCD986SK 세포 및 HaCaT 세포를 48 well plate에 계대 배양 후 작약 및 천마추출물을 12시간 전 처리하고 PBS로 1회 세척 후 UVA를 조사하였다. 그리고 24시간 후에 상층액을 취하여 10,000rpm에서 5분간 원심분리 하였다. 다음으로 96 well plate에 상층액 50㎕과 농도 1mM의 에이피엠에이(4-aminophenylmercuric acetate;APMA)를 넣어 잘 섞어준 후, MMP-1 효소 활성은 37℃에서 6시간 반응시키고, MMP-13 효소 활성은 37℃에서 40분간 반응시켰다. 마지막으로 MMP-1과 MMP-13에 해당하는 기질 용액을 첨가하여 섞어준 후 여기파장 340nm, 방출파장 490nm에서 1시간 동안 5분 간격으로 형광정도를 측정하였다.To investigate the inhibitory effect of MMP-1 and MMP-13 on collagenase activity, which is the most important component of ECM, after passage of CCD986SK cells and HaCaT cells in 48 well plates, peony and sperm extracts were treated 12 hours before PBS. UVA was irradiated after washing once. After 24 hours, the supernatant was taken and centrifuged for 5 minutes at 10,000 rpm. Next, add 50 µl of the supernatant and 1 mM AMP (4-aminophenylmercuric acetate; APMA) to a 96 well plate, and then mix well. The MMP-1 enzyme activity was reacted at 37 ° C. for 6 hours and the MMP-13 enzyme activity. Reacted for 40 minutes at 37 ° C. Finally, after adding and mixing the substrate solutions corresponding to MMP-1 and MMP-13, the fluorescence was measured at an interval of 5 minutes for 1 hour at an excitation wavelength of 340 nm and an emission wavelength of 490 nm.
2. 실험결과2. Experimental Results
도7 및 도8에서와 같이, MMP-1과 MMP-13의 활성이 작약 및 천마추출물의 농도 의존적으로 저해됨을 확인할 수 있다(도7, 도8).As shown in Figures 7 and 8, it can be seen that the activity of MMP-1 and MMP-13 is inhibited in a concentration-dependent manner of peony and cheonma extract (Figs. 7 and 8).
즉, 본 발명의 주름개선용 기능성 화장품은 콜라겐(collagen)의 합성 촉진 효능 및 콜라게나아제(collagenase)의 활성 저해 효능을 통하여 주름을 개선할 수 있다.In other words, the functional cosmetics for wrinkle improvement of the present invention can improve wrinkles through collagen synthesis promoting effect and collagenase activity inhibiting effect.
본 발명은 상기에서 언급한 바와 같이 바람직한 실시예와 관련하여 설명되었으나, 본 발명의 요지를 벗어남이 없는 범위 내에서 다양한 수정 및 변형이 가능하다. 따라서 본 발명의 청구범위는 이건 발명의 진정한 범위 내에 속하는 수정 및 변형을 포함한다.While the invention has been described in connection with the preferred embodiment as mentioned above, various modifications and variations are possible without departing from the spirit of the invention. Therefore, the claims of the present invention include modifications and variations that fall within the true scope of the invention.
도1은 작약 및 천마추출물 제조의 실시예를 나타내는 순서도.1 is a flow chart showing an embodiment of the preparation of peony and cheonma extract.
도2는 피부 노화 과정을 나타내는 개념도.2 is a conceptual diagram showing the skin aging process.
삭제delete
삭제delete
삭제delete
삭제delete
도3 및 도4는 각각 CCD986SK 세포 및 HaCaT 세포를 이용한 작약 및 천마추출물의 콜라겐 합성 촉진 효능을 나타내는 그래프.3 and 4 are graphs showing collagen synthesis promoting efficacy of peony and cheonma extract using CCD986SK cells and HaCaT cells, respectively.
도5는 ELISA에 의한 작약 및 천마추출물의 콜라겐 합성 촉진 효능을 나타내는 그래프.Figure 5 is a graph showing the collagen synthesis promoting efficacy of peony and cheonma extract by ELISA.
도6은 작약 및 천마추출물이 루시페라아제 활성도에 미치는 영향을 나타내는 그래프.Figure 6 is a graph showing the effect of peony and cheonma extract on luciferase activity.
도7 및 도8은 CCD986SK 세포 및 HaCaT 세포를 이용한 작약 및 천마추출물의 콜라게나아제 활성 저해 효능을 나타내는 그래프.7 and 8 are graphs showing the collagenase activity inhibitory effect of peony and cheonma extract using CCD986SK cells and HaCaT cells.
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070100456A KR100893912B1 (en) | 2007-10-05 | 2007-10-05 | Anti-wrinkle Cosmetics comprising Paeonia lactiflora and Gastrodia elata extracts as an effective component |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020070100456A KR100893912B1 (en) | 2007-10-05 | 2007-10-05 | Anti-wrinkle Cosmetics comprising Paeonia lactiflora and Gastrodia elata extracts as an effective component |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20090035274A KR20090035274A (en) | 2009-04-09 |
KR100893912B1 true KR100893912B1 (en) | 2009-04-20 |
Family
ID=40760749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020070100456A KR100893912B1 (en) | 2007-10-05 | 2007-10-05 | Anti-wrinkle Cosmetics comprising Paeonia lactiflora and Gastrodia elata extracts as an effective component |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100893912B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11389393B2 (en) | 2016-07-29 | 2022-07-19 | Amorepacific Corporation | Composition for inhibiting sebum secretion comprising peach sprout extract |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102025634B1 (en) * | 2017-01-23 | 2019-10-04 | 명지대학교 산학협력단 | Cosmetic composition containing gastrodiae elata for prevention of skin-aging |
KR101991936B1 (en) * | 2017-07-07 | 2019-10-01 | (주)에스디생명공학 | Composition for Preventing or Improving Skin Wrinkle Comprising Enzyme Treated Extract of Gastrodia as Active Ingredient |
KR101999258B1 (en) * | 2017-07-07 | 2019-07-12 | (주)에스디생명공학 | Composition for Improving Skin Conditions Comprising Enzyme Treated Extract of Gastrodia as Active Ingredient |
KR102418101B1 (en) | 2017-11-30 | 2022-07-08 | (주)아모레퍼시픽 | Composition for preventing or alleviating intrinsic aging comprising paeoniflorin or albiflorin |
KR102074993B1 (en) * | 2018-01-23 | 2020-03-17 | 대구한의대학교산학협력단 | A food composition for anti-wrinkle comprising the extract of steamed gastrodiae rhizoma and method for preparing the same |
KR101996021B1 (en) * | 2018-03-14 | 2019-07-03 | 사단법인 무주천마사업단 | Method for producing Gastrodia elata powder with increased functionality and removing off-flavor |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002205933A (en) * | 2001-01-05 | 2002-07-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing extract of orchidaceous plant |
KR20050047779A (en) * | 2003-11-18 | 2005-05-23 | 주식회사 에스티씨나라 | Composition for preventing or treating dementia and improving cognitive function comprising oriental medicine extracts as active ingredient |
KR20070019120A (en) * | 2005-08-11 | 2007-02-15 | 주식회사 코리아나화장품 | Anti-Wrinkle Cosmetic Composition Comprising the Extract of Paeonia lactiflora as Active Ingredient |
-
2007
- 2007-10-05 KR KR1020070100456A patent/KR100893912B1/en not_active IP Right Cessation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002205933A (en) * | 2001-01-05 | 2002-07-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing extract of orchidaceous plant |
KR20050047779A (en) * | 2003-11-18 | 2005-05-23 | 주식회사 에스티씨나라 | Composition for preventing or treating dementia and improving cognitive function comprising oriental medicine extracts as active ingredient |
KR20070019120A (en) * | 2005-08-11 | 2007-02-15 | 주식회사 코리아나화장품 | Anti-Wrinkle Cosmetic Composition Comprising the Extract of Paeonia lactiflora as Active Ingredient |
Non-Patent Citations (1)
Title |
---|
황금과 천마의 학습 및 기억에 미치는 영향/대한한의학회지,제23권 2호, 2002년 6월 29일* |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11389393B2 (en) | 2016-07-29 | 2022-07-19 | Amorepacific Corporation | Composition for inhibiting sebum secretion comprising peach sprout extract |
Also Published As
Publication number | Publication date |
---|---|
KR20090035274A (en) | 2009-04-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100893912B1 (en) | Anti-wrinkle Cosmetics comprising Paeonia lactiflora and Gastrodia elata extracts as an effective component | |
CN106266587B (en) | Orchid extract and its preparation method and application | |
US9044490B2 (en) | Active ingredient obtained from Cichorium intybus for acting on the barrier function of the skin that is similar to that of vitamin D | |
KR100825450B1 (en) | Skin anti-wrinkle cosmetics composition containing Forsythiae Fruit extract | |
JP2003194809A (en) | Drug treating skin itching, skin roughness, sensitive skin, and for skin whitening by suppressing production- releasing of stem cell factor | |
CN106994135B (en) | Sea grape extract with function of inhibiting allergy, preparation method and application | |
JPWO2003084302A1 (en) | Anti-aging agent | |
JP2021519806A (en) | A method for producing a coconut enzyme-treated extract having an increased tricine content, and a composition for whitening, wrinkle improving, anti-inflammatory, anti-allergic, and moisturizing produced thereby. | |
KR20100014100A (en) | Cosmetic composition containing fermented extracts with salt of natural materials | |
JP7090886B2 (en) | Hydrolyzate of watery rose apple extract and method for producing the hydrolyzate and use of the hydrolyzate | |
JP6034921B1 (en) | Phalaenopsis orchid extract, its preparation method and its application (THEACTIVE EXTRAACTOPPHALAENOPSIS, PREPARATIONMETHODANDSETHEREOF) | |
Kim et al. | Anti-wrinkle effects of extracts and solvent fractions from Nymphoides peltata on CCD-986sk | |
KR102334376B1 (en) | Cosmetic composition for skin improvement using Rhus javanica L. | |
TW201328719A (en) | Collagen production promoter | |
WO2024055536A1 (en) | Caspase-1 activity inhibitor having antioxidant activity and use thereof | |
KR20080061080A (en) | Cosmetic composition comprising tuber melanosporum | |
CN109820842A (en) | Batatasins III are preparing the application in drug and cosmetics | |
JP3496967B2 (en) | Antiplasmin agent | |
Lee et al. | Evaluating the effect of Luffa cylindrica stem sap on dermal fibroblasts; An invitro study | |
KR20060134653A (en) | Cosmetic composition for improvement of blood flow | |
KR102162662B1 (en) | Pharmaceutical Composition for Improvement of Atopic Dermatitis Containing Extract of Glycyrrhiza uralensis and Donkey Hide Gelatin | |
CN112842954A (en) | Anti-inflammatory and soothing composition and application thereof in cosmetics | |
KR101477552B1 (en) | A pharmaceutical composition for the treatment of atopic dermatitis and method of production thereof | |
KR102034436B1 (en) | Composition For Treating And Preventing Atopic Dermatitis Comprising Ternstroemia kwangtungensis Merr. Extracts | |
KR20240007827A (en) | Acpg |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
N231 | Notification of change of applicant | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130410 Year of fee payment: 5 |
|
FPAY | Annual fee payment |
Payment date: 20140410 Year of fee payment: 6 |
|
LAPS | Lapse due to unpaid annual fee |